Nathan Nagel

Nathan Nagel current roles. 

1.CEO of the Fratrem Group Ltd 

2. Board Adviser at Quest Prehabilitation telehealth programmes

3. Board Adviser at Digistain Breast Cancer Risk Profiling Technology

4. Faculty at Barts X Medicine digital health program 

5. Mentor to founders on the Cancer Tech Accelerator 

Connect with Nathan Nagel on LinkedIn


Mr Nathan Nagel is an entrepreneur with 23 years’ experience on the commercial side of healthcare with 13 years’ experience of being an executive director. Nathan has deep connections and understanding of the markets of the UK, EU, USA and Middle East. He is currently the (1) CEO of the Fratrem Group Ltd, (2) Board Adviser at Quest Prehab (3) Board Adviser at Digistain (4) Faculty at Barts X Medicine digital health program and (5) Mentor to founders on the CRUK Capital Enterprise Cancer Tech Accelerator. His past executive experience includes CEO at Gamlen Tableting Ltd (Pharmaceuticals), Managing Director of Sanyal Bio LLC (Liver disease), CEO of Neuro-Bio Ltd (Neuroscience), CEO of Oncology Pharma Ltd (Market research company), and Managing partner of LifeScience Ventures Ltd (Healthcare Venture Capital). Prior to leading companies Nathan worked in commercial roles for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career.